HOW2WORKtoday announced the global launch of the HOW2WORK Collectible Trading Cards (CTC): The Monsters Series 3. The new series introduces fresh The Monsters sketches and paintings by the artist Kasing Lung, including his LABUBU character – which sold over USD 1.8 billion in revenue in 2024 and ignited this year's worldwide craze for collectibles. https://mma.prnewswire.com/media/2804269/20251017_sakaxh2w_02_V3_1.jpg […]

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Semler Scientific, Inc. (NASDAQ:SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=174014&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Dow Inc. (NYSE:DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=174015&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=174016&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

The DJS Law Group reminds investors that it is investigating claimsagainstFluor Corporation (“Fluor” or “the Company”) (NYSE: FLR) for violations of securities laws. The investigation centers on whether the Company made false and/or misleading statements or omitted information critical to investors. On August 1, 2025, Fluor announced its second-quarter financial results and reduced its full-year

TheSchall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstV.F. Corporation (“VF” or “the Company”) (NYSE: VFC)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities between

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstCytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics ” or “the Company”) (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CYTK during the

The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. (“Savara ” or “the Company”) (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SVRA during the

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstFluor Corporation (“Fluor” or “the Company”) (NYSE: FLR) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's